India "misinterpreted" WHO on vax plants; Germany checks cheap AIDS drug import scheme;

> A parliamentary panel in India says it was "abundantly clear" that the decision to suspend the licenses of three public vaccine-making plants was based on "a major misconception and misinterpretation" of WHO's assessment of them. Story

> German police are investigating pharma distributors suspected of importing cheap AIDS vaccines from Africa and selling them at inflated prices. Story

> Japan has suspended vaccines made by Pfizer and Sanofi-Aventis while regulators investigate the deaths of four children. Item

> Giant robots count and process medications at the UC San Francisco Medical Center. Article

> "The operating environment for pharma is worsening rapidly," says Morgan Stanley, as it downgrades the multinational pharmaceutical companies in Europe. Story

> India may be facing a shortage of professionals in the pharma outsourcing sector. Article

> WuXi PharmaTech will build and operate a cGMP-compliant 25,000-square-foot facility in Shanghai to store and test stability samples for Bristol-Myers Squibb. BMS-WuXi release

> Pharma is among Canadian manufacturing sectors investing in distribution facilities to meet retailers' daily replenishment requirements. Story

> Colorado-based Tolmar has selected Pilgrim Software's Risk, Compliance and Quality Management solution. Pilgrim Software release

> Merck KGaA has appointed Friedhelm Felten head of corporate procurement with responsibility for global purchasing activities. Story